Nasal Esketamine in addition to oral Antidepressants: Aid with treatment-resistant Depression?

被引：0
|
作者：
Lenz, Bernd [1 ]
机构：
[1] Univ Klinikum Erlangen, Psychiatr & Psychotherapeut Klin, Erlangen, Germany
来源：
FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE | 2019年 / 87卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：604 / 605
页数：2
相关论文
共 50 条
  • [11] Esketamine (Spravato) for Treatment-Resistant Depression
    Jalloh, Mohamed
    AMERICAN FAMILY PHYSICIAN, 2020, 101 (06) : 339 - 340
  • [12] Intranasal esketamine in treatment-resistant depression
    Carruthers, Nicholas
    Singh, Jaskaran
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [13] Efficacy and safety of esketamine nasal spray plus an oral antidepressant in elderly patients with treatment-resistant depression
    Ochs-Ross, R.
    Daly, E.
    Zhang, Y.
    Lane, R.
    Lim, P.
    Foster, K.
    Hough, D.
    Manji, H.
    Drevets, W.
    Sanacora, G.
    Adler, C.
    McShane, R.
    Gaillard, R.
    Singh, J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S355 - S356
  • [14] EFFICACY AND SAFETY OF ESKETAMINE NASAL SPRAY PLUS AN ORAL ANTIDEPRESSANT IN ELDERLY PATIENTS WITH TREATMENT-RESISTANT DEPRESSION
    Ochs-Ross, Rachel
    Daly, Ella J.
    Zhang, Yun
    Lane, Rosanne
    Lim, Pilar
    Foster, Karen
    Hough, David
    Manji, Husseini
    Drevets, Wayne C.
    Sanacora, Gerard
    Adler, Caleb
    McShane, Rupert
    Gaillard, Raphael
    Singh, Jaskaran B.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2019, 27 (03): : S139 - S140
  • [15] Efficacy and Safety of Esketamine Combined with Antidepressants for Treatment-Resistant Depression: A Meta-Analysis
    Liu, Peng
    Zhang, Shan-Shan
    Liang, Yun
    Gao, Zi-Jun
    Gao, Wei
    Dong, Bu-Huai
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2022, 18 : 2855 - 2865
  • [16] Esketamine: a glimmer of hope in treatment-resistant depression
    Upinder Kaur
    Bhairav Kumar Pathak
    Amit Singh
    Sankha Shubhra Chakrabarti
    European Archives of Psychiatry and Clinical Neuroscience, 2021, 271 : 417 - 429
  • [17] POST HOC ANALYSES OF ESKETAMINE NASAL SPRAY PLUS AN ORAL ANTIDEPRESSANT IN ELDERLY PATIENTS WITH TREATMENT-RESISTANT DEPRESSION
    Ochs-Ross, Rachel
    Daly, Ella J.
    Zhang, Yun
    Lane, Rosanne
    Lim, Pilar
    Foster, Karen
    Hough, David
    Manji, Husseini
    Drevets, Wayne C.
    Sanacora, Gerard
    Adler, Caleb
    McShane, Rupert
    Gaillard, Raphael
    Singh, Jaskaran B.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2019, 27 (03): : S140 - S141
  • [18] Approval of esketamine for treatment-resistant depression Reply
    Turner, Erick H.
    LANCET PSYCHIATRY, 2020, 7 (03): : 236 - 236
  • [19] The role of intranasal esketamine in treatment-resistant depression
    Fraga, A.
    Esteves-Sousa, D.
    Facucho-Oliveira, J.
    Albuquerque, M.
    Costa, M.
    Espada-Santos, P.
    Moutinho, A.
    EUROPEAN PSYCHIATRY, 2021, 64 : S478 - S479
  • [20] Esketamine: a glimmer of hope in treatment-resistant depression
    Kaur, Upinder
    Pathak, Bhairav Kumar
    Singh, Amit
    Chakrabarti, Sankha Shubhra
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2021, 271 (03) : 417 - 429
12345